Zymeworks (ZYME) Current Deferred Revenue (2022 - 2026)
Zymeworks (ZYME) recorded Current Deferred Revenue of $16.44 million in Q2 2026, up 331.3% from $3.81 million a year earlier and up 691.0% from the prior quarter.
Powered by 
Analysis
Zymeworks (ZYME) Current Deferred Revenue (2022 - 2026) Analysis & Trends
At the end of FY2025, Zymeworks reported Current Deferred Revenue of $2.42 million, down 90.6% from FY2024.
- Annual Current Deferred Revenue has a three-year compound annual growth rate of 0.9% (FY2022 to FY2025).
- Across earlier years, Current Deferred Revenue came in at $25.6 million in FY2024 (+591.9%), $3.7 million in FY2023 (+57.2%) and $2.35 million in FY2022.
- The Q2 2026 figure is the highest quarterly Current Deferred Revenue since Q1 2025.
- On a year-over-year basis, Current Deferred Revenue rose in three of the last seven quarters, with growth averaging 172.2%.
- Peak year-over-year performance for Current Deferred Revenue in the last five years was growth of 591.9% in Q4 2024, against a decline of 91.2% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.08 million (Q1 2026), $2.42 million (Q4 2025) and $3.2 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Zymeworks | 2.24 Bn | 1.27 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 16.66 Mn |
| Jun 30, 2026 | 16.44 Mn |
| Mar 31, 2026 | 2.08 Mn |
| Dec 31, 2025 | 2.42 Mn |
| Sep 30, 2025 | 3.20 Mn |
| Jun 30, 2025 | 3.81 Mn |
| Mar 31, 2025 | 23.50 Mn |
| Dec 31, 2024 | 25.60 Mn |
| Sep 30, 2024 | 27.19 Mn |
| Jun 30, 2024 | 5.52 Mn |
| Mar 31, 2024 | 3.44 Mn |
| Dec 31, 2023 | 3.70 Mn |
| Sep 30, 2023 | 93,000.00 |
| Jun 30, 2023 | 17.76 Mn |
| Mar 31, 2023 | 2.35 Mn |
| Dec 31, 2022 | 2.35 Mn |
| Sep 30, 2022 | 32.94 Mn |
API Access
Zymeworks Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ZYME&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "ZYME", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ZYME&period=max&api_key=YOUR_API_KEY");
const data = await res.json();